Genital Chlamydia trachomatis infections

Clinical Microbiology and Infection

Volumn 15, Issue 1, 2009, Pages 4-10

  Bébéar, Christiane ^a   de Barbeyrac, B ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Chlamydia trachomatis; Diagnosis; Epidemiology; Genital infections; Review; Treatment

Indexed keywords

MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHRONIC INFLAMMATION; DNA HYBRIDIZATION; ENZYME IMMUNOASSAY; EUROPE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENDER; GENITAL TRACT INFECTION; HUMAN; IMMUNE RESPONSE; INFECTION RATE; MALE; NEWBORN INFECTION; NONHUMAN; NONSPECIFIC URETHRITIS; NUCLEIC ACID AMPLIFICATION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROSTATITIS; REVIEW; RISK FACTOR; SEROLOGY; SEROTYPE; UTERINE CERVICITIS;

CHLAMYDIA TRACHOMATIS;

EID: 59349104373     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02647.x     Document Type: Review

References (61)

1. Hatch TP. Developmental biology. In: Stephens RS, ed. Chlamydia. Washington, DC: ASM Press, 1999; 29-67.
2. Schachter J. Infection and disease epidemiology. In: Stephens RS, ed. Chlamydia. Washington, DC: ASM Press, 1999; 139-169.
3. Manavi K. A review on infection with Chlamydia trachomatis. Best Pract Res Clin Obstet Gynaecol 2006; 20: 941-951.
4. Paget WJ, Zbinden R, Ritzler E et al. National laboratory reports of Chlamydia trachomatis seriously underestimate the frequency of genital chlamydial infections among women in Switzerland. Sex Transm Dis 2002; 29: 715-720.
5. Baud D, Jaton K, Bertelli C, Kulling JP, Greub G. Low prevalence of Chlamydia trachomatis infection in asymptomatic young Swiss men. BMC Infect Dis 2008; 8: 45.
6. Warszawski J. Dépistage systématique des infections àChlamydia trachomatis: Il est temps d'agir. Bull Epidémiol Hebd 2006; 38: 275-276.
7. Barbeyrac de B, Raherison S, Bernabeu A et al. Dépistage de l'infetion àChlamydia trachomatis dans la population d'étudiantes des universités de Bordeaux, France, 2004. Bull Epidémiol Hebd 2006; 38: 288-290.
8. van de Laar MJ, Fenton KA, Ison C. Update on the European lymphogranuloma venereum epidemic among men who have sex with men. Euro Surveill 2005; 10: E050602.
9. de Vries HJ, van der Bij AK, Fennema JS et al. Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior. Sex Transm Dis 2008; 35: 203-208.
10. Herida M, Sednaoui P, Couturier E et al. Rectal lymphogranuloma venereum, France. Emerg Infect Dis 2005; 11: 505-506.
11. Spaargaren J, Fennema HS, Morre SA, de Vries HJ, Coutinho RA. New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam. Emerg Infect Dis 2005; 11: 1090-1092.
12. Herida M, de Barbeyrac B, Sednaoui P et al. Rectal lymphogranuloma venereum surveillance in France 2004-2005. Euro Surveill 2006; 11: 155-156.
13. Ward H, Martin I, Macdonald N et al. Lymphogranuloma venereum in the United Kingdom. Clin Infect Dis 2007; 44: 26-32.
14. Herida M, Kreplack G, Cardon B, Desenclos JC, de Barbeyrac B. First case of urethritis due to Chlamydia trachomatis genovar L2b. Clin Infect Dis 2006; 43: 268-269.
15. van de Laar MJ, Morre SA. Chlamydia: A major challenge for public health. Euro SuHveill 2007; 12: E1-E2. Available at: http://www.eurosurveillance.org/em/v12n10/1210-221.asp
16. Peipert JF. Clinical practice. Genital chlamydial infections. N Engl J Med 2003; 349: 2424-2430.
17. Hicks D. Complications of Chlamydia trachomatis infection in men. In: Moss TR, ed. International handbook of Chlamydia, 3rd edn. Haslemere, UK: Alden Press, 2008; 99-109.
18. Barbeyrac de B, Papaxanthos Roche A, Mathieu C et al. Chlamydia trachomatis in subfertile couples undergoing an in vitro fertilization program: A prospective study. Eur J Obstet Gynecol Reprod Biol 2006; 129: 46-53.
19. Rogstad K. Complications in the female and their management. In: Moss T, ed. International handbook of Chlamydia, 3rd edn. Haslemere, UK: Alden Press, 2008; 111-121.
20. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: Impact on human reproduction. Hum Reprod Update 1999; 5: 433-447.
21. Hammerschlag MR. Chlamydia trachomatis in children. Pediatr Ann 1994; 23: 349-353.
22. Stenberg K, Mardh PA. Persistent neonatal chlamydial infection in a 6-year-old girl. Lancet 1986; 2: 1278-1279.
23. Darville T. Chlamydia spp. In: Nataro JP, Blaser J, Cunningham-Rundles S, eds, Persistent bacterial infections. Washington, DC: ASM Press, 2000; 229-261.
24. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: From cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58: 686-699.
25. Ward ME. Mechanisms of Chlamydia-induced disease. In: Stephens RS, ed. Chlamydia. Washington, DC: ASM Press, 1999; 171-210.
26. Dean D, Suchland RJ, Stamm WE. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis 2000; 182: 909-916.
27. Belland RS, Sudmoze MA, Carne DD et al. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci USA 2007; 98: 13984-13989.
28. Michel CEC, Sonnex C, Carne CA et al. Chlamydia trachomatis load at matched anatomic sites: Implications for screening strategies. J Clin Microbiol 2007; 45: 1395-1402.
29. Schachter J, Chernesky MA, Willis DE et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005; 32: 725-728.
30. Gaydos CA, Ferrero DV, Papp J. Laboratory aspects of screening men for Chlamydia trachomatis in the new millenium. Sex Transm Dis 2008; 35: 545-550.
31. Essig A. Chlamydia and Chlamydophila. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. Manual of clinical microbiology, 9th edn. Washington, DC: ASM Press, 2007; 1021-1035.
32. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10: 160-184.
33. Warford A, Chernesky M, Peterson EM. Laboratory diagnosis of Chlamydia trachomatis infections. In: Gleaves CA, ed. Cumitech 19A. Washington, DC: ASM Press, 1999, pp. 1-18.
34. Michel CE, Solomon AW, Magbanua JP et al. Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: A comparative study. Lancet 2006; 367: 1585-1590.
35. Mahilum-Tapay L, Laitila V, Wawrzyniak JJ et al. New point of care Chlamydia Rapid Test-bridging the gap between diagnosis and treatment: performance evaluation study. BMJ 2007; 335: 1190-1194.
36. Leber AL, Hall GS, LeBar WD. Nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. In: Sharp SE, ed. Cumitech 44. Washington, DC: ASM Press, 2006, pp. 1-38.
37. Schachter J, Chow JM, Howard H, Bolan G, Moncada J. Detection of Chlamydia trachomatis by nucleic acid amplification testing: Our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised. J Clin Microbiol 2006; 44: 2512-2517.
38. Schachter J, Hook EW, Martin DH et al. Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: All NAATs are not created equal. J Clin Microbiol 2005; 43: 1372-1373.
39. Ripa T, Nilsson P. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: Implications for use of PCR diagnostic tests. Euro Surveill 2006; 11: E061109.
40. Lynagh Y, Walsh A, Crowley B. First report of the new variant strain of Chlamydia trachomatis in Ireland. Epi-Insight 2007; 8: 4.
41. Moghaddam A, Reinton N. Identification of the Swedish Chlamydia trachomatis variant among patients attending a STI clinic in Oslo, Norway. Euro Surveill 2007; 12: E070301.
42. Hoffmann S, Jensen JS. Mutant Chlamydia trachomatis in Denmark. Euro Surveill 2007; 12: E7-E8.
43. de Barbeyrac B, Raherison S, Cado S et al. French situation concerning the Swedish Chlamydia trachomatis variant. Euro Surveill 2007; 12: E11-E12.
44. Frost EH, Deslandes S, Veilleux S, Bourgaux-Ramoisy D. Typing Chlamydia trachomatis by detection of restriction fragment length polymorphism in the gene encoding the major outer membrane protein. J Infect Dis 1991; 163: 1103-1107.
45. Rodriguez P, Vekris A, de Barbeyrac B, Dutilh B, Bonnet J, Bebear C. Typing of Chlamydia trachomatis by restriction endonuclease analysis of the amplified major outer membrane protein gene. J Clin Microbiol 1991; 29: 1132-1136.
46. Klint M, Fuxelius HH, Goldkuhl RR et al. High-resolution genotyping of Chlamydia trachomatis strains by multilocus sequence analysis. J Clin Microbiol 2007; 45: 1410-1414.
47. Pedersen LN, Podenphant L, Moller JK. Highly discriminative genotyping of Chlamydia trachomatis using omp1 and a set of variable number tandem repeats. Clin Microbiol Infect 2008; 14: 644-652.
48. Persson K. The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections. Best Pract Res Clin Obstet Gynaecol 2002; 16: 801-814.
49. Jones R, Boag F. Screening for Chlamydia trachomatis - opportunistic approaches have little evidence to support them. BMJ 2007; 334: 703-704.
50. Low N. Screening programmes for chlamydial infection: When will we ever learn? BMJ 2007; 334: 725-728.
51. Suchland RJ, Geisler WM, Stamm WE. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp. Antimicrob Agents Chemother 2003; 47: 636-642.
52. Mourad A, Sweet RL, Sugg N, Schachter J. Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother 1980; 18: 696-698.
53. Lefevre JC, Lepargneur JP. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France). Sex Transm Dis 1998; 25: 350-352.
54. Somani J, Bhullar VB, Workowski KA, Farshy CE, Black CM. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181: 1421-1427.
55. Dreses Werringloer U, Padubrin I, Kohler L, Hudson AP. Detection of nucleotide variability in rpo B in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis. Antimicrob Agents Chemother 2003; 47: 2316-2318.
56. Dessus-Babus S, Bébéar CM, Charron A, Bébéar C, de Barbeyrac B. Sequencing of gyrase and topoisomerase. IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained in vitro. Antimicrob Agents Chemother 1998; 42: 2474-2481.
57. Misyurina OY, Chipitsyna EV, Finashutina YP et al. Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides. Antimicrob Agents Chemother 2004; 48: 1347-1349.
58. Wang SA, Papp JR, Stamm WE, Peeling RW, Martin DH, Holmes KK. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: A meeting report. J Infect Dis 2005; 191: 917-923.
59. CDC. Sexually transmitted diseases treatment guidelines. MMWR 2006; Report No. 55 (RR-11).
60. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections - A meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29: 497-502.
61. Walker CK, Wiesenfeld HC. Antibiotic therapy for acute pelvic inflammatory disease: The 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007; 44(suppl): S111-S122.